Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

ProQR Therapeutics (PRQR) Return on Sales (2021 - 2025)

ProQR Therapeutics' Return on Sales history spans 5 years, with the latest figure at 0.02% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.02% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.03%, a 1.0% decrease, with the full-year FY2025 number at 0.03%, down 1.0% from a year prior.
  • Return on Sales hit 0.02% in Q4 2025 for ProQR Therapeutics, up from 0.04% in the prior quarter.
  • Over the last five years, Return on Sales for PRQR hit a ceiling of 0.01% in Q2 2024 and a floor of 0.73% in Q4 2021.
  • Historically, Return on Sales has averaged 0.14% across 5 years, with a median of 0.05% in 2023.
  • The widest YoY moves for Return on Sales: up 55bps in 2022, down -8bps in 2022.
  • Tracing PRQR's Return on Sales over 5 years: stood at 0.73% in 2021, then soared by 76bps to 0.17% in 2022, then surged by 89bps to 0.02% in 2023, then dropped by -23bps to 0.02% in 2024, then increased by 17bps to 0.02% in 2025.
  • Business Quant data shows Return on Sales for PRQR at 0.02% in Q4 2025, 0.04% in Q3 2025, and 0.03% in Q2 2025.